Background: Currently studies conflict on the impact on mortality of right
bundle branch block development after transplantation. Most studies conclud
e that right bundle branch block does not affect patient survival. However,
no distinction is made between patients in whom right bundle branch block
progresses and those in whom it remains unchanged during follow-up. The obj
ective of this study is to assess clinical or survival differences between
patients who develop right bundle branch block and those who do not, and al
so to analyze these differences depending on progression of this conduction
abnormality.
Materials and Methods: Ninety-seven consecutive heart transplant recipients
with more than 1 year's survival were analyzed. Twelve-lead standard ECGs
were performed during the first week after transplantation, which allowed f
or classification of patients depending on the presence or absence of right
bundle branch block. Subsequently, throughout the first year, 2 groups wer
e identified, depending on increase of the conduction defect. The groups we
re compared and factors determining the presence of right bundle branch blo
ck and progression of the conduction defect were found. Survival curves for
the conduction defect were also compared.
Results: Fifty percent of the patients developed right bundle branch block
after transplantation; it was progressive in 10. Progressive right bundle b
ranch block was related to greater renal dysfunction (odds ration [OR] = 10
.8; confidence interval [CI] = 2-58; p = 0.006), a larger number of rejecti
ons (p = 0.01), and a greater death rate (OR = 12.8; CI = 2.5-64; p = 0.002
). The presence of progressive right bundle branch block was an independent
predictor of long-term mortality (OR = 27.9; CI = 4.2-186.3; p = 0.0006).
Conclusions: The development of right bundle branch block after transplanta
tion is related to intraoperative factors and to a greater number of reject
ions. The presence of this conduction disorder, particularly if it progress
es during the first year, identifies a sub-group of patients with a poorer
long-term prognosis.